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ABSTRACT 
Endovascular aneurysm repair (EVAR) was initially introduced as a less invasive alternative to conventional open repair. 
EVAR was subsequently adopted as a treatment option for abdominal aortic aneurysm. In Korea, open repair is more widely 
available than EVAR, although EVAR can be performed in several hospitals. Due to the rapidly aging population in Korea, 
there has been a shift from private healthcare to government-regulated universal coverage and EVAR may be a more feasible 
option for cardiovascular interventionalists in these days. The improvement of EVAR was rapidly attained by many pioneers 
for the last two decades. Although issues such as indications and durability of EVAR remain to be elucidated, its application 
can be extended further of milder invasiveness-related effects on comorbidities and less discomfort to patients. Aortic stent-
grafting has been performed for various aortoiliac pathologies over the last 13 years at our cardiovascular center.1-3) This 
article presents a comprehensive review on EVAR by focusing on the clinical trials, indications, complications, and expertise 
in decision making for EVAR. (Korean Circulation J 2007;37:459-463) 
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Introduction 
 
Endovascular abdominal aortic aneurysm (AAA) repair 
was initially introduced as a less invasive alternative to con-
ventional open repair-Parodi in 1990,4) and was adopted as 
one of the treatment options for AAA. In the past, end-
ovascular aneurysm repair (EVAR) was accepted as a com-
patible method to more conventional method from the vi-
ewpoint of its safety and favorable outcomes.5-7) Earlier 
clinical studies on EVAR have reported significant decrease 
in intensive care unit (ICU) stay, hospital stay, major com-
plications such as bleeding, and the 30-day mortality. Fur-
thermore, due to its advantages including prompt recovery 
and early ambulation, EVAR had emerged as a substitute 
to surgery particularly for treating elderly patients with 
multiple comorbidities. However, some conflicting results 
have been reported from more recent studies that assessed 
the mid to long-term impacts of EVAR.  
For instance, some studies8)9) revealed inconsistencies in 
the early positive outcomes of EVAR. While one study 
reported three to six years of sustained benefits, another 
study raised concerns regarding its accepted durability. In 
addition, other studies10-14) discussed concerns regarding 
the increased risks of possible graft failure, that would ne-
cessitate re-intervention or surgical conversion in the later 
phase. Endovascular Aneurysm Repair (EVAR) trial 1, that 
included patients who could endure both surgery and 
EVAR, reported patients significantly lower 30-day mor-
tality rates, but an increase of post-operative re-interven-
tion rates with EVAR.15) 
In EVAR trial 2, researchers compared patients who 
received EVAR with only medically treated patients without 
intervention, and found that the former group had sign-
ificantly higher rates of all-cause and aneurysm-related 
mortality, and EVAR was reported to be less cost-effective. 
Therefore, the researchers concluded that careful case sel-
ection and clinical follow-ups are critical in EVAR.16) In 
the Dutch Randomized Endovascular Aneurysm Manage-
ment (DREAM) trial, open repair group and endovascular 
repair group were compared based on the accumulated 
aneurysm-related mortality rates. The results obtained 
did not reveal any significant differences in the primary 
end-points. Therefore, short-term advantages such as im-
mediate post-interventional safety and early positive out-
comes should neither be considered the best determinants 
of prognosis of endovascular repair, nor be related to long- 
term outcomes.17)18) However, there have not been any 
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randomized prospective clinical trials on the long-term 
outcomes in patients with a high operative risk. 
 
Endovascular Aneurysm Repair in Korea 
 
In Korea, open repair is more widely available than 
EVAR, although EVAR can be performed in several hospitals. 
The approved devices in Korea are Zenith (Cook Medical, 
Bloomington, IN), Excluder (Gore & Associates, Flagstaff, 
AZ), and AneuRx (Medtronic, Inc., Santa Rosa, CA). In 
the past 2 years, only 138 EVARs have been performed in 
Korea. Zenith was used for 24 procedures in 2005 and 84 
procedures in 2006; Excluder was used for 13 procedures 
in 2005 and 8 procedures in 2006; the remaining 9 pro-
cedures were performed using SEAL (S&G biotech, Sung-
nam, Gyeonggi-do, Korea), a domestic device that has been 
recently approved for use in Korea. Due to the rapidly 
aging population in Korea, there has been a shift from pri-
vate healthcare to government-regulated universal coverage. 
Korean government insurance bears for 90% expense of 
the EVAR device and the patient bears the remaining 10%. 
 
Natural History of Abdominal Aortic 
Aneurysm and Interventional Decision-making 
 
The mortality rate of ruptured AAA is more than 90%, 
however, it can be decreased by the emergent implantation 
of stent-graft.19) Hence, it is crucial to manage AAA prior 
to its rupture, although the possibility and timing of rupture 
may vary considerably for each case. Generally, the risk of 
aneurysmal rupture increases substantially if the diameter 
of AAA ranges between 5 to 6 cm. For example, the annual 
risk of AAA rupture is 5-11%, when the diameter of 
AAA is more than 5 cm.20) The following factors impose a 
high risk for AAA rupture: AAA diameter or annual pro-
gression of more than 0.6 cm, heavy smoking, family his-
Fig. 1. Successful endovascular aneurysmal repair in a patient with abdominal aortic aneurysm (AAA). Pre-interventional (A) and post-stent-graft 
implantation (B) aortograms show marked improvement in distal blood flow propagation. Pre-interventional (C) and post-stent-graft implantation (D) 
computer tomography show stabilization of the aortic diameter and extraluminal thrombosis without leakage. 
A B
C D
 
 
Chul Min Ahn, et al：Endovascular Aneurysm Repair in Korea·461 
tory of vascular diseases, poorly controlled hypertension, 
eccentric shape of the aneurysm, and female gender.21) 
In our experiments with patients, mortality rates could 
not be reduced considerably by performing emergency pro-
cedures after AAA rupture; this was due to progressive 
multi-organ failures including renal shut-down. Therefore, 
it is critical to detect the progression of AAA during the 
early stage with close clinical and radiographic follow-ups. 
Fig. 1 shows a successful endovascular stent-graft repair in 
a patient with AAA which was impending rupture. Fig. 2 
shows an urgent stent-graft repair in a patient with aor-
tic rupture who was diagnosed with Bechet disease. 
Indication of and Expertise  
in Endovascular Aneurysm Repair 
 
From our experiences, accurate pre-procedural analysis 
using imaging techniques and the selection of the most app-
ropriate instruments are very effective for the successful 
management of the cases of AAA and biiliac artery with 
vascular tortuosity. More importantly, the level of exper-
ience and expertise of the surgeons were found to be cri-
tical for successful implantations of stent-grafts. 
Following procedures and instruments were used for 
cases that were previously considered as contraindications 
Fig. 2. An urgent stent-graft repair in a patient with abdominal aortic rupture who was diagnosed with Beçhet disease. Pre-interventional computer 
tomography (A) shows leakage around the lower abdominal aorta, and the post-interventional image (B) shows no further deterioration or complication. 
A B
 
Fig. 3. Type I endoleak after stent-graft implantation. A: immediate post stent-graft implantation aortogram shows no visible endoleak. B: one year after 
stent-graft implantation, there occurred type I endoleak (black arrow) with newly developed angulation of proximal stent-graft edge due to remodeling of 
the abdominal aorta. 
BA 
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for EVAR (acute-angled aneurysm extremely extended to 
the renal or biiliac artery): incorporation of an uncovered 
stent for facilitating adequate stent-graft apposition, the 
staged embolization of the internal iliac artery, and vertical 
modification of the puncture site. With these novel tech-
niques, the number of successful cases of EVAR has incre-
ased gradually when compared to that of conventional open 
repair. Considering our past data, a relatively acceptable 
indication of stent-grafting for AAA is an aneurysmal dia-
meter ranging from 5 to 5.5 cm, depending on the patient’s 
native vessel diameter or the rate of aneurysm enlargement 
(1 cm/year).  
New onset or aggravation of pain and other medically 
intractable conditions such as rupture with either acute 
or chronic presentation despite adequate medical treatments, 
are indications for EVAR.22)23) However, with considerable 
variations in every aortic aneurysm, it is not easy to clearly 
state the appropriateness of EVAR, particularly white tre-
ating patients with grave comorbidities, even in large, ran-
domized clinical trials.  
 
Complication and Durability 
 
Manifested complications such as migration of stent-
graft, spontaneous endoleak (Fig. 3) or porosity, and stent 
thrombosis (Fig. 4) have been detected during followups, 
leading to either re-intervention or operative correction in 
some cases.24) The current classification system for endo-
leaks and endotension is detailed in Table 1.25) Type I or III 
endoleak should be corrected because the aneurysmal sac 
in these cases would be exposed to systemic blood pressure, 
leaving no possibility for spontaneous resolution.25)26) There-
fore, in the absence of a sound evidence of initial endo-
leak, it is critical to detect the existence of endoleak by using 
computed tomography follow-up. Moreover it is helpful to 
pursue additional interventions such as coiling or redo stent- 
graft implantation to prevent the increase in pressure over-
load to the aneurysm. 
In general, cases that required additional procedures were 
considered as clinically unsuccessful. However, broadening 
the implication of success and by considering subsequent 
procedures important, the impact of EVAR on the effective 
prognosis of patients would be substantial. In addition, it 
is important to manage comorbidities intensively with ant-
ihypertensive, antilipidemic, and antiplatelet agents for be-
tter patients’ prognosis and to consider stent durability and 
patency against the remodeling of aorta or thrombosis. 
Table 1. Classification scheme for endoleaks and endotension25) 
Description; source of perigraft flow 
Endoleaks (type) 
I 
A 
B 
C 
II 
A 
B 
III 
A 
B 
 
IV 
Attachment site leaks 
Proximal end of endograft 
Distal end of endograft 
Iliac occluder (Plug) 
Branch leaks (without attachment site connection) 
Simple or to-and-fro (from only 1 patent branch) 
Complex or flow-through (with 2 or more patent branches) 
Graft defect 
Junctional leak or modular disconnect 
Fabric disruption (midgraft hole) 
Minor (<2 mm; eg, suture holes), Major (≥2 mm) 
Graft wall (fabric) porosity (<30 days after graft placement) 
Endotension (type) 
A 
B 
C 
D 
With no endoleak 
With sealed endoleak (virtual endoleak) 
With type I or type III leak 
With type II leak 
 
 
A B
Fig. 4. Complications after stent-graft implantation: two cases of thrombosis of the left limb of stent-graft who were treated with open fem-to-fem bypass 
graft repair. 
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Conclusion 
 
The research and development of EVAR has gained con-
siderable attention and speed over the past decades due to 
the substantial effort from the pioneers. Although some 
difficult questions remain to be answered, such as the correct 
indications for and durability of EVAR, this intervention 
does have advantages such as less invasiveness-related effects 
on comorbidities and greater comfort to patients.  
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